Financials data is unavailable for this security.
View more
Year on year Curative Biotechnology Inc 's net income fell 14.35% from a loss of 4.67m to a larger loss of 5.34m despite flat revenues.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -339.98% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Balance sheet in USDView more
| Current ratio | 0.008 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -303.18%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
